[A novel gemcitabine delivery system].

Akio Sugitachi, Miyuki Ikeda, Teppei Matsuo, Satoshi Nishizuka, Hiroyuki Nitta, Masahiro Takahashi, Takeshi Takahara, Naoko Ito, Yasushi Hasegawa, G. Wakabayashi

Research output: Contribution to journalArticle

Abstract

Indocyanine green (ICG) is specifically excreted through the biliary tracts. The authors applied ICG as a carrier of gemcitabine (GEM) to devising a novel drug delivery system. Our newly devised chitin flakes, ICG and GEM were mixed together. Then physiological saline solution was added to the mixture to form the system. The release profiles of GEM and ICG from the system were examined at various times in vitro. Anticancer activities of the GEM and ICG delivered from the system were detected by MTT assay method using human pancreatic cancer cell lines. The novel system was visco-elastic green sol at room temperature and changed to gel at body temperature. Seventy to 80% of GEM was gradually delivered from the system in 24 hours, and 30 to 50% of ICG was slowly released over 24 hours. The released GEM favorably demonstrated anticancer activities against the cancer cells, while the ICG released from the system showed no oncolytic activities. These suggested that our devised system would be clinically useful as a novel tool in cancer chemotherapy.

Original languageEnglish
Pages (from-to)2445-2447
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume38
Issue number12
Publication statusPublished - 2011 Nov
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of '[A novel gemcitabine delivery system].'. Together they form a unique fingerprint.

Cite this